Nucleai

Spatial biology takes center stage! 🌐 Nature Magazine presents a groundbreaking collection mapping tumor evolution across space and time, with studies covering 20 cancer types, many in 3D, across ~2,000 individuals and 12 publications. This initiative provides invaluable resources, emphasizing the importance of spatial insights in cancer biology and equipping researchers with powerful tools to advance precision oncology. Check out The Human Tumor Atlas Network (HTAN) Collection: https://hubs.li/Q02WpxsM0 #spatialbiology #cancerresearch #oncology #precisionmedicine

🌠Thrilled to share that Nucleai has been recognized as one of the Top 10 Spatial Biology Companies of 2024 by Genetic Engineering & Biotechnology News. This recognition highlights our mission to advance next-generation therapeutics through AI-driven spatial insights, reshaping precision medicine. Proud to be among a standout group leading healthcare innovation🚀https://hubs.li/Q02WnXzB0 #SpatialBiology #SpatialBiomarkers #SpatialAI #DigitalPathology #PrecisionMedicine

Joining us at World ADC next week? Our Director of Application Science, Jason Reeves, will be at the conference, sharing how AI-driven spatial biomarkers and diagnostics advance patient selection for antibody-drug conjugate (ADC) therapies. Visit us at booth 607 or book a meeting with Jason. Mark your calendars and let’s connect! https://hubs.li/Q02WhFgw0 #SpatialAI #biomarkers #spatialbiomarkers #ADCs #AntibodyDrugConjugates #worldADC #WorldADC24 #PrecisionMedicine #biomarkers #CDx

🚨 New Blog Alert! 🚨 Highlights from our panel at World CDx! Experts from Moderna, Amgen and AstraZeneca dive into how AI and digital pathology are enabling next-gen therapeutics. Check out our latest blog for key takeaways! https://hubs.li/Q02WcVDP0 #WorldCDx #sptialAI #DigitalPathology #PrecisionMedicine #SpatialBiomarkers #AI #CDx #Biomarker Oscar P., Rolando E. Yanes, PhD, Christine K. Ward, Mark Gustavson

World ADC kicks off next week (Nov 4-7) in San Diego! Visit us at booth 607 to discover how our AI Pathology & Spatial Biomarker Solutions provide actionable insights that enhance biomarker and diagnostic strategies for antibody-drug conjugates (ADCs). Find out how to determine the right patient selection cutoff based on the bystander effect and tumor heterogeneity. Book a meeting with our team, and let’s explore how we can drive better outcomes together! https://hubs.li/Q02V_1Ld0 #WorldADC #WorldADC24 #AIPathology #DigitalPathology #SpatialBiomarkers #PrecisionMedicine #biomarker #BystanderEffect #ADCs #AntibodyDrugConjugates Neelima Kumar,Martin Koch, Jason Reeves

Fall conference season is in full swing! Next up: Digital Pathology Association's PathVisions 2024 in Orlando, Nov 3-5. 📍Join us at #PV2024 to meet our Head of Pathology, Dr. Ken Bloom, and our VP of Strategic Partnerships, Vikas Ahuja, and learn how our AI Pathology & Spatial Biomarker Solutions are driving advancements in clinical trials and diagnostics. Book a meeting with our team!. Book a meeting with our team! https://hubs.li/Q02VWh8c0 #PathVision24, #AIPAthology #Pathology #PrecisionMedicine #SpatialBiomarkers #DPA

In his latest piece for MedCity News our CEO Avi Veidman shares why Spatial AI is a game-changer for boosting the impact of antibody-drug conjugates in cancer treatment. Check out his insights on targeting cancer with precision! https://bit.ly/48ksxYY #ADCs #AntibodyDrugConjugates #SpatialAI #SpatialBiomarkers #DigitalPathology #AIPathology #PrecisionMedicine #Biomarkers

In honor of Breast Cancer Awareness Month🎗️, we take the opportunity to explore the advancements reshaping treatment options. Spatial AI is offering a deeper understanding of tumor biology, enabling more personalized and effective care for patients. Discover how these insights are improving outcomes and driving the future of breast cancer care. ➡️ https://bit.ly/3YA8B0N #BreastCancer #BreastCancerAwarenessMonth #DigitalPathology #SpatialBiomarkers #Biomarkers #HER2 #PrecisionMedicine #AIPathology

Day 1 at the Spatial Biology for Drug Development Summit in Boston has been full of insightful discussions! The day kicked off with a panel featuring our Director of Application Science, Jason Reeves alongside leaders from BMS, Gilead, and Eli Lilly, exploring the challenges and opportunities in adopting spatial technologies across drug development. Later, Jason presented on how AI Spatial Intelligence is driving innovation in the field. We’re proud to be part of these important conversations shaping the future of drug development. Stay tuned for more updates, and visit us at Booth #1 to connect with our team! https://bit.ly/3AbYCWc #spatialbiology #drugdevelopment #spatialbiomarker #biomarkers #digitalpathology Lauri Diehl Deidre Dalmas, PhD, fRSB, Shih-Ying Wu, Benjamin Chen, MD, PhD

🚨 Spatial Biology for Drug Development starts tomorrow! 🚨 Don’t miss our sessions: 🔹8:45 AM: Addressing Common & Diverse Challenges in Adopting & Implementing Spatial Technologies Across Drug Development, featuring Benjamin Chen, MD, PhD (BMS), Lauri Diehl (Gilead), Shih-Ying Wu (Eli Lilly), and our Director of Application Science, Jason Reeves. 🔹12:45 PM: Leveraging AI Spatial Intelligence to Enhance Drug Development and Patient Selection, presented by Jason Reeves. Be sure to book a meeting with our team to learn more about how AI Spatial Analysis is transforming drug development. See you there! https://lnkd.in/gSFpai8u #SpatialBiology #SpatialBiomarker #AIpathology #DigitalPathology #PrecisionMedicine